Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, New York
- Most recent report
- 10-Q, filed Aug 13, 2026
- Incorporated
- Delaware
- Filings on record
- 532 filings
- On EDGAR
- CIK 1636651
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 39
News 8 of 140
- 8-K Current report on a material event Aug 13, 2026
- 8-K Leadership change Jul 8, 2026
- 8-K Shareholder vote results Jun 11, 2026
- 8-K Leadership change Jun 3, 2026
- 8-K Current report on a material event May 12, 2026
- 8-K Other events Apr 20, 2026
- 8-K Quarterly results Mar 18, 2026
- 8-K Other events Dec 18, 2025
Prospectuses and Registrations 8 of 35
- 424B3 Prospectus supplement for an offering Apr 27, 2026
- S-3 Shelf registration statement Apr 21, 2026
- S-8 Registration statement for an employee plan Mar 18, 2026
- 424B3 Prospectus supplement for an offering Dec 22, 2025
- S-3 Shelf registration statement Dec 15, 2025
- S-8 Registration statement for an employee plan May 14, 2024
- 424B5 Prospectus supplement for an offering Nov 15, 2023
- S-3 Shelf registration statement Nov 3, 2023
Proxies 8 of 22
- DEFA14A Extra proxy material Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2026
- DEF 14A Proxy statement for a shareholder vote Nov 7, 2025
- PRE 14A Preliminary proxy statement Oct 28, 2025
- PREM14A Oct 27, 2025
- DEFA14A Extra proxy material May 22, 2025
- DEF 14A Proxy statement for a shareholder vote May 22, 2025
- PRE 14A Preliminary proxy statement May 2, 2025
Ownership 8 of 264
- 144 Notice of a proposed sale of restricted stock Aug 24, 2026
- 144 Notice of a proposed sale of restricted stock Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- SCHEDULE 13G Large holder reported a passive stake Jul 29, 2026
Other 8 of 32
- ARS Annual report sent to shareholders Apr 27, 2026
- EFFECT Notice that a registration became effective Apr 24, 2026
- CORRESP Reply to SEC staff Apr 23, 2026
- UPLOAD Comment letter from SEC staff Apr 23, 2026
- EFFECT Notice that a registration became effective Dec 22, 2025
- CORRESP Reply to SEC staff Dec 19, 2025
- ARS Annual report sent to shareholders May 22, 2025
- ARS Annual report sent to shareholders Apr 24, 2024
Everything here comes from Ovid Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.